Example: Heart Attack
Clinical Trials on Glabellar Crease
Total 10000 results
-
NCT05751668SuspendedAnatomic Stage IV Breast Cancer AJCC v8 | Chemotherapy-Induced Peripheral Neuropathy | Metastatic Breast Carcinoma
-
NCT06065423CompletedTelerehabilitation | Breast Cancer Related Lymphedema
-
NCT03391206CompletedBreast Cancer Lymphedemas
-
NCT00998738TerminatedPain | Neuropathy | Stage IV Breast Cancer | Recurrent Breast Carcinoma
-
NCT06889610RecruitingColorectal Cancer Metastatic | Melanoma Metastatic | Triple Negative Breast Cancer Metastatic
-
NCT05522491Not yet recruiting
-
NCT05241925Not yet recruiting
-
NCT04549558Not yet recruitingMultimodal Ultrasonographic Assessment of Axillary Lymph Nodes in Patients With Breast Cancer
-
NCT04342546RecruitingBreast Cancer | Capsular Contracture Associated With Breast Implant
-
NCT03797482RecruitingBreast Cancer Female
-
NCT06070155CompletedTrace Elements Levels After Breast Cancer Radiotherapy
-
-
NCT03961880CompletedBreast Cancer Female
-
NCT07134933CompletedErector Spinae Plane Block
-
NCT06943313Enrolling by invitationBreast Cancers | PET / CT | PIK3CA Mutation-Related Tumors | PI3K Pathway Activated Tumors
-
NCT05234021CompletedHER2-positive Breast Cancer | Biosimilar | Patient Reported Outcome
-
NCT00171704CompletedHormone Sensitive Resected Primary Breast Cancer in Postmenopausal Women
-
NCT02746666CompletedBreast Cancer, Quality of Life
-
NCT06846437RecruitingUnrespectable Locally Advanced and or Metastatic HER2 Positive Breast Cancer Participants
-
NCT06856200RecruitingAdvanced HR - Positive, HER2 - Negative Breast Cancer | Resistant to (Neo)Adjuvant Endocrine Therapy
-
NCT06629896RecruitingBreast Cancer Screening and Diagnosis
-
NCT06358625Recruiting
-
-
NCT06133088RecruitingAdvanced HR-positive and HER2-negative Breast Cancer; CDK4/6 Inhibitor Treatment Failed
-
NCT05181202RecruitingLiposomal Doxorubicin Induced Hypersensitivity Reaction in Breast Cancer Patients
-
NCT03861975Active, not recruiting
-
NCT04880369WithdrawnBreast Cancer | Breast Neoplasms | Breast Cancer Female
-
NCT04441099TerminatedTriple Negative Breast Cancer | Advanced Solid Tumor | Advanced Cancer
-
NCT01147484CompletedRecurrent Breast Cancer
-
NCT03462251CompletedBreast Cancer | Hormone Receptor Positive Tumor | HER 2 Negative Breast Cancer
-
NCT01904903CompletedLeft Ventricular Function Systolic Dysfunction | HER2 Positive Breast Cancer
-
NCT01984866TerminatedTriple Negative, HER2+, Luminal B Breast Tumors (Stages II-III)in Female Patients
-
NCT01446159CompletedHormone-sensitive, HER-2 Negative Metastatic Breast Cancer
-
-
NCT01996410TerminatedBreast Cancer Stages I Through III
-
NCT05135026CompletedReduce Unnecessary Caesarean Section | Increase Institutional Delivery | Increase Antenatal Care
-
NCT05418985CompletedWomen's Breast Self Examination Beliefs | Women's Breast Self Examination Practice
-
NCT06534125RecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Hormone Receptor-Positive Breast Carcinoma | HER2-Negative Breast Carcinoma
-
NCT07478315Not yet recruiting
-
NCT07405385Not yet recruitingCancer | Breast Cancer | Neoplasm | Metabolic Flexibility
-
NCT07383818RecruitingHR Positive/HER2 Low Breast Cancer
-
NCT07338721RecruitingBreast Carcinoma | Sentinel Lymph Node Biopsy
-
NCT07235618Not yet recruitingLocally Advanced or Metastatic Breast Cancer
-
NCT07200427Not yet recruitingBreast Cancer Prevention
-
NCT07184749Not yet recruitingBreast Cancer | Chemotherapy-induced Peripheral Neuropathy
-
NCT07135661RecruitingBreast Cancer | Proton Therapy
-
NCT07009093RecruitingBreast Cancer | Cancer Distress
-
NCT06295744RecruitingEarly-stage Breast Cancer
-
NCT06080620RecruitingLocally Advanced Breast Cancer
-
NCT05983094Not yet recruitingBreast Cancer | Neoadjuvant Therapy
-
NCT05673694Recruiting
-
NCT05470348Recruiting
-
NCT05461534Not yet recruitingBreast Cancer | Sexual Dysfunction